Depakote Capsule
Product Images NDC 0074-6114

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Depakote (NDC 0074-6114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium Is A Stable Co-ordination Compound Comprised Of Sodium Valproate And Valproic Acid In A 1:1 Molar Relationship And Formed During The Partial Neutralization Of Valproic Acid With 0.5 Equivalent Of Sodium Hydroxide. Chemically It Is Designated As Sodium Hydrogen Bis(2-propylpentanoate). Divalproex Sodium Has The Following Structure: (Depakote Sprinkle Capsules Spl 01)

FDA Label Image

Figure 1 (Depakote Sprinkle Capsules Spl 02)

FDA Label Image

Figure 2 (Depakote Sprinkle Capsules Spl 03)

FDA Label Image

1 (Depakote Sprinkle Capsules Spl 04)

FDA Label Image

2 (Depakote Sprinkle Capsules Spl 05)

FDA Label Image

3 (Depakote Sprinkle Capsules Spl 06)

FDA Label Image

4 (Depakote Sprinkle Capsules Spl 07)

FDA Label Image

Ndc 0074–6114–13 100 Sprinkle Capsules Depakote® Sprinkle Capsules Divalproex Sodium Delayed Release Capsules 125 mg Valproic Acid Activity Dispense The Accompanying Medication Guide To Each Patient. Rx Only Abbvie (Depakote Sprinkle Capsules Spl 08)

FDA Label Image

Description: Delisted Image (Depakote Sprinkle Capsules Spl 09)